Low density lipoprotein(LDL)アフェレシス

Size: px
Start display at page:

Download "Low density lipoprotein(LDL)アフェレシス"

Transcription

1 Low density lipoprotein LDL Hisashi MAKINO, Mariko HARADA-SHIBA 1. はじめに Low density lipoprotein LDL 著者連絡先 mshiba@ncvc.go.jp familial hypercholesterolemia; FH LDL FH LDL 600 1,000 mg/dl 1) LDL proprotein convertase subtilisin/kexin type 9 PCSK9 autosomal recessive hypercholesterolemia adaptor protein autosomal recessive hypercholesterolemia; ARH 3-hydroxy- 3-methyl-glutaryl-CoA HMG-CoA LDL FH LDL LDL-C 400 mg/dl 250 mg/dl LDL LDL LDL B LDL heparininduced extracorporeal precipitation HELP FH peripheral artery disease; PAD LDL FH LDL 2. LDLアフェレシスの方法 1) 単純血漿交換 (plasma exchange) FH 10 2) 二重膜濾過法 (double filtration plasmapheresis) 2 LDL very low density lipoprotein VLDL 2) high density lipoprotein HDL VLDL LDL

2 3)LDL 吸着法 (liposober system) LDL LDL B VLDL LDL Lp a 3) HDL B 150 ml LA15 2 LDL NaCl 5 LA15 LDL LDL ACE 3. LDLアフェレシスの実際 FH LDL 4 6 FH 1 LDL 2 1 LDL 25 kg 10 LDL LDL FH FH LDL FH 図 1 LDL small dense LDL-C LDL 80 small dense LDL-C LDL 4) 4. LDL アフェレシスの抗動脈硬化作用 FH LDL LDL-C intercellular adhesion molecule-1 ICAM-1 endothelial leukocyte adhesion molecule-1 ELAM-1 5) plasminogen activator inhibitor-1 PAI-1 6) LDL LDL 6) NO 7) LDL small dense LDL 図 1 LDL 8) LDL NaCl elution 図 2a mass spectrometry MS MS/MS 198

3 図 2 LDL proprotein convertase subtilisin/kexin type 9 PCSK9 LDL PCSK9 apolipoprotein C- ApoC- LDL 図 2b Tavori LDL PCSK9 LDL 9) LDL-C 1 LDL LDL PAD LDL LDL-C Ikeya LDL PAD LDL 10) PAD LDL LDL 5. FHにおけるLDLアフェレシスの治療目標と心血管予後への効果 LDL-apheresis atherosclerosis regression study LAARS FH LDL 11) FH LDL 3 20 LDL 表 1 4) Græsdal ) FH LDL 1 / LDL 199

4 表 1 LDL 4) 1 F M F F M F M F FH 200 mg/dl 6. おわりに 図 3 CABG, coronary artery bypass grafting; MI, myocardial infarction; PTCA, percutaneous transluminal coronary angioplasty. 300 mg/dl 100 mg/dl LDL Hokuriku-FH-LDL- Apheresis Study FH LDL percutaneous coronary intervention PCI coronary artery bypass grafting CABG 13) LDL-C 図 3 LDL LDL-C LDL FH PCSK9 14) microsomal triglyceride transfer protein 15) FH LDL-C 1 /1 2 FH LDL LDL LDL-C FH 利益相反の開示 COI 文献 1) Goldstein JL, Brown MS: The Metabolic Basis of Inherited Disease 5 th ed, ed by Yokoyama S, Hayashi R, et al, MacGraw-Hill, New York, ) Kikkawa T, Yokoyama S, Hayashi R, et al: Specificity of various plasmapheresis techniques for treatment of 200

5 hypercholesterolemia. Current Practice in Therapeutic Plasmapheresis (International Congress Series, No 694), ed by Shiokawa Y, Inoue N, Excerpta Medica, Amsterdam, 1985, ) Yokoyama S, Hayashi R, Kikkawa T, et al: Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Characterization and experimental use in hypercholesterolemic rabbits. Arteriosclerosis 4: ,1984 4) Makino H, Harada-Shiba M: Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia. Ther Apher Dial 7: , ) Sampietro T, Tuoni M, Ferdeghini M, et al: Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation 96: , ) Kobayashi S, Oka M, Moriya H, et al: LDL-apheresis reduces P-Selectin, CRP and fibrinogen -- possible important implications for improving atherosclerosis. Ther Apher Dial 10: , ) Tamai O, Matsuoka H, Itabe H, et al: Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 95:76-82, ) Yuasa Y, Osaki T, Makino H, et al: Proteomic analysis of proteins eliminated by low-density lipoprotein apheresis. Ther Apher Dial 18: , ) Tavori H, Giunzioni I, Linton MF, et al: Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresis. Circ Res 113: , ) Tsurumi-Ikeya Y, Tamura K, Azuma K, et al: Sustained inhibition of oxidized low-density lipoprotein is involved in the long-term therapeutic effects of apheresis in dialysis patients. Arterioscler Thromb Vasc Biol 30: , ) Kroon AA, Aengevaeren WR, van der Werf T, et al: LDL- Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 93: , ) Græsdal A, Bogsrud MP, Holven KB, et al: Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia. J Clin Lipidol 6: 331-9, ) Mabuchi H, Koizumi J, Shimizu M, et al: Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL- Apheresis Study Group. Am J Cardiol 82: , ) Roth EM, McKenney JM, Hanotin C, et al: Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia. N Engl J Med 367: , ) Cuchel M, Meagher EA, du Toit Theron H, et al: Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. Lancet 381: 40-6,

実績

実績 1. Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes. Diabetes Ther. 2018 Feb;9(1):383-394 GLP 2. Incidence of diabetes

More information

1) Tsujita, Y., Kuroda, M., Shimada, Y., Tanzawa, K., Arai, M., Kaneko, I., Tanaka, M., Masuda, H., Tarumi, C., Watanabe, Y. and Fujii, S.:CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl

More information

C/NC : committed/noncommitted

C/NC : committed/noncommitted C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a

More information

第4回クッキーテスト研究会研究報告集(PDF)

第4回クッキーテスト研究会研究報告集(PDF) 2007 H19.8 2007 5 26 () 2 3 7 9 12 14 15 18 25 29 1 2 () (g g kcal) mg/dl.mg/dl ( U/mlhr).(mg/dl*U/ml) 50.2 158.6cm 70.7kg 28.1kg/ 92.5cm ( ) () ( ) (.(.-.)g/ml.(-.) g/ml ((MS) MS MS cm 2 MS () 3 4 122/74

More information

untitled

untitled 21 + TC : Toatal Choelesterol TGtriglyceride CE : cholesterol ester VLDLvery low density lipoprotein IDLintermediate density lipoprotein LDL low density lipoprotein HDL high density lipoprotein FFAfree

More information

21-07_後藤論文.smd

21-07_後藤論文.smd 2015; 21: 5866 Yoichi Goto: Current status and future perspective of cardiac rehabilitation in Japan. J Jpn Coron Assoc 2015; 21: 5866 I 1 1 3 1 2 3 QOL 2 Fig. 1 1 196070 AMI AMI 1980 AMI CABG comprehensive

More information

本文.indd

本文.indd CQ ACC/AHA PECO PatientExposure Comparison OutcomePECO low-density lipoprotein cholesterol LDL C cholesterol cholesterol intensive OR agressive CQ target LDL C PubMed Systematic Reviews Clinical Study

More information

研究成果報告書

研究成果報告書 21 4 25 peroxynitrite angiotensin II ETA MEK/ERK pathway endothelin-1 EDHF (EDHF) EDHF EDHF EDHF 2 [phosphodiesterase 3 (PDE3) cilostazol metformin thromboxane A2 ozagrel eicosapentaenoic acid (EPA) angiotensin

More information

PTCA CABG 2PTCA & CABG 3 4 PTCA CABG 1 2 3PTCA & CABG 4 5 PTCA CABG follow-up Japanese Circulation Journal Vol. 64, Suppl. IV, 2000

PTCA CABG 2PTCA & CABG 3 4 PTCA CABG 1 2 3PTCA & CABG 4 5 PTCA CABG follow-up Japanese Circulation Journal Vol. 64, Suppl. IV, 2000 19981999 JR PTCACABG 1 2 PTCA 3 PTCA 4 OP-CABG MID-CAB PTCACABG 1 PTCA PTCA CABG 2 1 PTCA PTCA PTCA PTCA PTCA 2CABG CABG CABG CABG 3PTCA CABG Japanese Circulation Journal Vol. 64, Suppl. IV, 2000 1009

More information

45-6 セレクション2_斯波●5_柴.indd

45-6 セレクション2_斯波●5_柴.indd 家族性高コレステロール血症をめぐって 家族性高コレステロール血症の遺伝子異常と病態の多様性 斯波真理子 国立循環器病研究センター研究所病態代謝部 はじめに高コレステロール血症が冠動脈疾患における主要な危険因子であることは古くより知られ,Khachadurianらは,1973 年に遺伝性高コレステロール血症には優性遺伝を示すものと, 劣性遺伝を示すものが存在することを報告した 1). 優性遺伝型式をとる高コレステロール血症については,

More information

1315 (15)

1315 (15) (14) 1315 (15) 1316 (16) 1317 (17) 1318 (18) 1319 (19) 1320 (20) 1321 (21) 1322 quinidine, disopyramide, and procainamide in isolated atrial myocytes : Mediation by 2) Inoue H, et al: Effects of pentisomide

More information

TRS4505.ec6..

TRS4505.ec6.. 糖尿病の療養指導 211 [ 日本糖尿病学会編 ] 別刷 レクチャー : 糖尿病療養指導に必要な知識 1 5 食後高血糖と脂質異常症の同時評価, 是正とその意義 原納 優, 前田亜耶, 名引順子, 原納晶著 211 年 9 月発行 発行所株式会社 診断と治療社 21 5 1 13 1,2 4 1 1 2 3 4 Key Words CMT Summary 154 CMT 1 IGT2 IFG3 1

More information

Understanding Stem Cell Transplant 2007

Understanding Stem Cell Transplant 2007 Understanding Stem Cell Transplant IMF International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax: 818-487-7454

More information

The Heart Healthy Tocotrienol Complex Tocomin SupraBio

The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio 1. Fact Sheet No. 317; World Health Organization (WHO), 2007 2. LLOYD-JONES D. et al. Circulation

More information

Journal Club 2017/05/30 Tomohiro Matsumoto PGY-2

Journal Club 2017/05/30 Tomohiro Matsumoto PGY-2 Journal Club 2017/05/30 Tomohiro Matsumoto PGY-2 本 の論 March 21, 2017 2 Introduc)on 3 : (CIN) 3 25% 44µmol/L(0.5mg/dL) CIN 4 European Society of Urogenital Radiology. ESUR guidelines on contrast media,

More information

VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3

VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3 VENTANA ALK D5F3 Rabbit Monoclonal Antibody OptiView ALK D5F3 2 OptiView ALK D5F3 11 10 79.3%31% 18% 80 85NSCLC 40% 1,2 1 1018 ALK ALK 2 ALK 3 5% ALK EML4 EML4-ALK Coild-Coil ALK ALK 3,4,5 2 6 EGFR 50%

More information

437“ƒ

437“ƒ et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer

More information

TNF-α MCP-1 IL-6 TNF-α 4 vascular endothelial growth factor VEGF IL-6 TNF-α 2 CRP CRP CRP CRP CRP CRP + CRP CRP CRP CRP 3 PAI-1 PAI-1 PAI-1 PAI-1 5 抗炎

TNF-α MCP-1 IL-6 TNF-α 4 vascular endothelial growth factor VEGF IL-6 TNF-α 2 CRP CRP CRP CRP CRP CRP + CRP CRP CRP CRP 3 PAI-1 PAI-1 PAI-1 PAI-1 5 抗炎 Online publication December 21, 2010 総 説 特集 : 糖尿病の血管病変を再考する アディポサイトカインと血管病変 要旨 : J Jpn Coll Angiol, 2010, 50: 549 554 Key words: atherosclerosis, obesity, inflammation, adipocytokine, adiponectin はじめに

More information

VOL33NO.3/2010 A B A B p-erk1/2 Time (min) 0 1 2 5 10 15 30 60 90 120 Erk1/2 Time (min) 0 1 2 5 10 15 30 60 90 120 p-vasp VASP C D enos/gapdh x-fold vs sham 2.0 1.5 1.0 0.5 * 0 ANP (-) (+) (-)

More information

Cytokine-adsorbing hemofilter:バクスター セプザイリス(AN69ST膜hemofilter)

Cytokine-adsorbing hemofilter:バクスター セプザイリス(AN69ST膜hemofilter) Cytokine-adsorbing hemofilter AN69ST hemofilter Acute Care Kazuhiro MORIYAMA, Noriko ONOZUKA, Hidehito TSUNASHIMA 1. はじめに 1) CRRT AN69ST 2) sepxiris 2014 7 1 2 AN69ST 2. AN69 膜の開発経緯 1960 1969 著者連絡先 Acute

More information

Effect of Supplementation of Sulfur-Containing Amino Acids to a Low-Soy Protein Diet Containing Cholesterol on Plasma Cholesterol Levels in Rats Tokik

Effect of Supplementation of Sulfur-Containing Amino Acids to a Low-Soy Protein Diet Containing Cholesterol on Plasma Cholesterol Levels in Rats Tokik Effect of Supplementation of Sulfur-Containing Amino Acids to a Low-Soy Protein Diet Containing Cholesterol on Plasma Cholesterol Levels in Rats Tokiko MIZUNO, Hiroko ABE, Ryuji HIRANO and Koji YAMADA

More information

1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):

More information

審査報告書(案)

審査報告書(案) 19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET

More information

1990 1010 21 (1)(2) (3) (4) Vol. 21 No. 111999 3

1990 1010 21 (1)(2) (3) (4) Vol. 21 No. 111999 3 201980Japan as number one 21American as number one 20 198020 19701980 1980 1990 2 Vol. 21 No. 111999 1990 1010 21 (1)(2) (3) (4) Vol. 21 No. 111999 3 SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSS

More information

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です 8. Page1 8. B 1 5) 6) 2099 2370 50 400 mg 19 (1) 1) (a) 78.9% 30/38 4 3 35.7% 5/14 71.4% 10/1485.7% 12/142 1 83.3% 5/63 2 1 1 1 8. Page2 (b) 2099 1897 82.4% 1562/1897 2 84.0% 1298/1545 3 2 80.4% 472/58779.0%

More information

untitled

untitled gold standard CT gold standard 1960 1970 1980 1990 CABG ) New device 2000 DES Cumulative Survival rate 100 90 80 70 60 SVD DVD TVD 96.0 94.5 80.7 n=453 n=220 n=198 91.9 87.4 64.2 50 1 2 3 4 5 6 7 8 9

More information

日本臨床麻酔学会 vol.34

日本臨床麻酔学会 vol.34 392 Vol.34 No.3/May 2014 日本臨床麻酔学会第 32 回大会シンポジウム日臨麻会誌 Vol.34 No.3, 392 396, 2014 長期予後を考えた周術期管理とは? 周術期虚血性心疾患とニコランジル * 木下浩之 [ 要旨 ] ニコランジル投与が狭心症患者の長期予後を改善することは周知の事実である. 一方で, ニコランジル周術期投与の有用性については, 数少ない臨床研究で検討されているにすぎない.

More information

Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Ora

Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Ora Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Oral Physiology, Hokkaido University School of Dentistry,

More information

asymmetric dimethylarginine Table 1 CKD / 2 GFR 60 GFR(ml/min/1.73 m 2 )= age Cr Stage Definition GFR(ml/min/1.73

asymmetric dimethylarginine Table 1 CKD / 2 GFR 60 GFR(ml/min/1.73 m 2 )= age Cr Stage Definition GFR(ml/min/1.73 Online publication January 14, 2011 総 説 第 50 回総会シンポジウム 2 循環器内科系 : 内皮と脈管疾患 血管 - 腎連関と asymmetric dimethylarginine 1 2 1 要旨 : CKD: chronic kidney disease CKD Asymmeteric dimethylarginen ADMA ADMA ADMA ADMA

More information

スライド 1

スライド 1 1 2006 msv 2 2011 3 CT 2011 10mSv 10 40mSv 4 2012 217mSv 5 (CT) 2012 50 60mSv 6 2012 510mSv BRCA25 310 10mSv3% BRCA60-280% 3 5m Sv 1m Sv 12% . http://www.rea.or.jp/ire/pdf/report4.pdf 1.10 20 SMR 1.00

More information

- 1 -

- 1 - - 1 - 35:261-262 2005.12 35:153-154 2005.12-2 - 15500383 15-17 2006.3 [] 1 17(5):161-165 2005.5 32(3):130-134 2005.6 Synovial fringe 1 22(3):322 2005.10 Pancoast 56(13):1663-1666 2005.12 [] 22(5):788-795

More information

1) Roth, J., Glick, S. M., Yalow, R. S. and Berson, S. A.: Hypoglycemia: A potent stimulus to secretion of growth hormone. Science, 140, 987-988, 1963. 2) Ogawa, N.: Routine Ultramicro-Measurement of Human

More information

橡

橡 TP T-13i AST ALT ALP Y CTP LOH CHE CRP 8.7 id 0.4 mg/d 21 AWL 131U/L 257 LU/L 12 111/L 234 11J/L 344 IU/L 0.30 mid No K a BUN ORE UA 142 meq/1 4.3 meqa 108 meqa 15.8 met! 0.71 mg/di 5.0 mg/d CEA 5_5 n8/m1

More information

動脈硬化 び 血漿 ア ポ 蛋 白 濃 度 は そ れ ぞ れ, TG 136.2±6.8, HDL-Ch ±5.2, apo A-II 31.0±1.4, C-II 3.8±0.3, apo mg/100mlで ±0.36%で C-III あ っ た. あ っ た. Ch 58.6±4.0, apo Vol. 7.6±0.4, apo B-48比 の 性 差 も検 討 し た が, apo 210.4±14.1,

More information

[] 1

[] 1 0 [] 1 [] 2 [] 2010 22 0% 20% 40% 60% 80% 100% 15.4 65.2 10.8 8.6 12,000 2010 22 2020 32 2030 42 2040 52 2015 27 14.3 63.3 12.3 10.1 10,000 2020 32 13.2 63.0 11.9 11.9 8,000 2025 37 12.3 62.9 10.6 14.2

More information

日本皮膚科学会雑誌第121巻第11号

日本皮膚科学会雑誌第121巻第11号 β Clin Rheumatol Arthritis Rheum Am J Cardiol J Rheumatol J Rheumatol Arthritis Rheum Arthritis Rheum Arthritis Rheum Rheumatology Oxford Rheumatology Oxford Br J Dermatol Arch Dermatol Ann Rheum Dis

More information

Table 1 Age Adjusted Mortality in CHD(1985) (rate/ person/year) Fig. 1 The Cause of Death. (K. Uemura, Z. Pisa)

Table 1 Age Adjusted Mortality in CHD(1985) (rate/ person/year) Fig. 1 The Cause of Death. (K. Uemura, Z. Pisa) The Forefront of Lipid Nutrition Kazuo KONDO and Tamami IWAMOTO The National Institute of Health and Nutrition (1-23-1, Toyama, Shinjyuku-ku Tokyo, 162) Abstract : The mortality of heart disease in Japan

More information

126mg/dL HbA1c 6.5 1, TG/HDL-C BMI Mann-Whitney U Logrank TG/HDL-C Cox SPSS Statistics ver22ibm EZR 5 ver2.1-2 TG/HDL-C TG/

126mg/dL HbA1c 6.5 1, TG/HDL-C BMI Mann-Whitney U Logrank TG/HDL-C Cox SPSS Statistics ver22ibm EZR 5 ver2.1-2 TG/HDL-C TG/ 原 著 31 462-467 2016 TG/HDL-C 10 TG/HDL-C TG/HDL-C 10 retrospective TG/HDL-Chomeostasis model assessment-insulin resistance HOMA-IR 10 TG/HDL-C TG/HDL-C HOMA-IR 75 2.6 1.4 10 2001 TG/HDL-C 2 TG/HDL-C TG/HDL-C

More information

E Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian

More information

~ 48 patience. Hypertension 1992; 19: 79-84. 32) Amamoto K, Okamura T, Tamaki S, et al. The association 21) Puddey IB, J.Beilin L, Vandongen R, L.Rouse I, Rogers of low-km mitochondrial acetaldehyde

More information

_心臓48-12_HO7_中田.indd

_心臓48-12_HO7_中田.indd Acute myocardial infarction with Cholesteryl-Ester Transfer Protein(CETP) deficiency // / Marohito Nakata, Namio Higa, Tami Mashidori, Mamoru Manita, Tomohiro Asahi, Kazuhiko Tabata Department of Cardiology,

More information

Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL Right Posted at the Inst

Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL   Right Posted at the Inst Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL http://hdl.handle.net/10130/526 Right Posted at the Institutional Resources for Unique Colle Available from

More information

Response of pre-and postoperative Glucose- Insulin-Kalium (GIK) loading in patients with valve replacement. Isao Sakashita*, Takeshi Ando*, Tetsunosuk

Response of pre-and postoperative Glucose- Insulin-Kalium (GIK) loading in patients with valve replacement. Isao Sakashita*, Takeshi Ando*, Tetsunosuk Response of pre-and postoperative Glucose- Insulin-Kalium (GIK) loading in patients with valve replacement. Isao Sakashita*, Takeshi Ando*, Tetsunosuke Matsukawa* *Department and Ken-ichi Asano*. of Thoracic

More information

untitled

untitled ( ) - 1 - - 2 - 38% 26% A) Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma 124 (J Clin Oncol 7: 126-131, 1989) 124 95 29 II 1 2,000mg/m 2 x 4 8g/m

More information

2009年133巻3号3月号.indb

2009年133巻3号3月号.indb Folia Pharmacol. Jpn.133 1 2 Chiroscience UCB S RR-..% AA C IC C/A A/ A R- II/ III II/III Chiroscience UCB S 1 - E-mail: koji_taya@maruishi-pharm.co.jp Author: Koji Taya, Satoshi Shimizu Title: Levobupivacaine

More information

BAANs理論に基づく保健指導プログラム暫定版

BAANs理論に基づく保健指導プログラム暫定版 WHO 4 5 10% L- -3 RNA L - 1960-3 RNA mrna Bio Activating Advanced Nutrients BAANs BAANs BAANs BAANs L- (NO) -3 EPA, DHA) RNA RNA DNA TNF- PAI-1 ( ) BAANs 40 50% 20% 1Kg 7,000Kcal 50Kcal 11 50Kcal

More information

ACS患者の最適な脂質低下療法を考える

ACS患者の最適な脂質低下療法を考える 提供 : サノフィ株式会社 座談会 Series Optimal LLT* を考える * Lipid Lowering Therapy ACS 患者の 最適な脂質低下療法を考える 於 : メルパルク京都 08 年 7 月 9 日開催 出席者 ( 発言順 ) 座長 赤阪隆史先生和歌山県立医科大学循環器内科教授 木村剛先生京都大学医学部附属病院循環器内科教授 伊苅裕二先生東海大学医学部内科学系循環器内科学教授

More information

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio 7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine

More information

untitled

untitled 5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg

More information

慢性膵炎

慢性膵炎 - - 121 , g CCK g g - kgkcal kgkcal - g,,, - G.I.Res ; 10 : - ; 13 : - ; 22 : - Meier RF, Beglinger C. Nutrition in pancreatic diseases. Best Pract Res Clin Gastroenterol ; 20 : - Pfutzer RH, Schneider

More information

無水エタノールによる硬化療法および鼻粘膜癒着処置を施行したオスラー病による難治性鼻出血の1例

無水エタノールによる硬化療法および鼻粘膜癒着処置を施行したオスラー病による難治性鼻出血の1例 119 874 2016 : 0 1cc : : : : : :WBC3 640/μl RBC 247 10 /μl PLT 22 9 10 /μl Hb 7 9g/dl PT APTT : : : 1ml 30G absolute ethanol Et 0 1 0 2ml 2mm 119 875 1 000mg/day Et 0 3ml Al Deen endoglin ALK1 1 3 a b

More information

1) Asa, S. L., et al.: Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenoma, Arch. Pathol. Lab. Med., 108: 40 `43, 1984. 2) Chi, B. H. and Kim, R. C.:

More information

日医総研ワーキングペーパー

日医総研ワーキングペーパー DRG 64 14 DRG IR-DRGJ-DRG R 2 NHS-Clinical Indicators PCICABG 36 250,418 9,286 11 10 0.4 HCFA-DRGAP-DRGAPR-DRGJ-DRG( ) IR-DRG(International Refined-DRG) J-DRG IR-DRG938 267 J-DRG( ) R J-DRG(0.3070) IR-DRG0.3905

More information

HEART'S Original A case of Brugada syndrome with a high defibrillation threshold in which defibrillation was successful by Active Can off defibrillation Keisuke Kawachi, Yukei Higashi, Yuuki Honda, Kouhei

More information

268 LSG 図 Lee ABCD 表 1 4 Age BMI C Duration Still DiaRem 表 1 4 HbA1c Ⅱ 対象と方法 1 17 LSG 6 3 Excess Weight Loss EWL BMI 25 kg/m 2 Hb

268 LSG 図 Lee ABCD 表 1 4 Age BMI C Duration Still DiaRem 表 1 4 HbA1c Ⅱ 対象と方法 1 17 LSG 6 3 Excess Weight Loss EWL BMI 25 kg/m 2 Hb 52 5 18 1 267 原著 ( 臨床研究 ) LSG ABCD DiaRem LSG 3 93.1 1 7.8 CR37.5 PR33.3 1 ABCD 5 DiaRem 12 LSG ABCD DiaRem LSG 腹腔鏡下スリーブ状胃切除術,ABCD スコア,DiaRem スコア Ⅰ はじめに Bariatric Surgery 2 1 metabolic surgery 2 ABCD 2

More information

提供 : サノフィ株式会社 座談会 心血管二次予防における LDL コレステロール管理 : Treat to Target vs. Fire and Forget 出席者 座長 木村一雄先生 伊苅裕二先生 横浜市立大学付属市民総合医療センター心臓血管センター教授 東海大学医学部内科学系循環器内科教授

提供 : サノフィ株式会社 座談会 心血管二次予防における LDL コレステロール管理 : Treat to Target vs. Fire and Forget 出席者 座長 木村一雄先生 伊苅裕二先生 横浜市立大学付属市民総合医療センター心臓血管センター教授 東海大学医学部内科学系循環器内科教授 提供 : サノフィ株式会社 座談会 心血管二次予防における LDL コレステロール管理 : Treat to Target vs. Fire and Forget 出席者 座長 木村一雄先生 伊苅裕二先生 横浜市立大学付属市民総合医療センター心臓血管センター教授 東海大学医学部内科学系循環器内科教授 安田 聡先生 国立循環器病研究センター心臓血管内科部門長 SAJP.ALI.15.11.3064 サノフィと

More information

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案) VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.

More information

胆石症

胆石症 ,. vs 64 .. vs. -, Ransohoff DF, Gracie W. Treatment of gallstones. Ann Intern Med ; 119 : - Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic

More information

GL_高野班_D.indd

GL_高野班_D.indd Circulation Journal Vol. 72, Suppl. IV, 2008 1443 PCI CCU STEMI CABG ST ST1 EBM ST ST ST ST ST ST 1 EBMEvidence-Based Medicine 1444 Circulation Journal Vol. 72, Suppl. IV, 2008 ACS ST T ST CLBBB ST ACS

More information

2 1,2 percutaneous transluminal coronary angioplasty: PTCA 3, PTCA PTCA PTCA PTCA American Heart Association AHA 75%

2 1,2 percutaneous transluminal coronary angioplasty: PTCA 3, PTCA PTCA PTCA PTCA American Heart Association AHA 75% 1 2 : Long-Term Prognosis in Patients With Single-Vessel or Double-Vessel Coronary Artery Disease: Does Successful Revascularization Achieved by Coronary Angioplasty Improve Late Outcome? Takanobu KAWAHARADA,

More information

日本内科学会雑誌第106巻第4号

日本内科学会雑誌第106巻第4号 特集 脂質異常症 : 実地診療におけるピットフォールから未来の治療まで 動脈硬化リスク 治療標的としての TG,HDL 要旨 高トリグリセライド (triglyceride:tg) 血症, 低 HDLコレステロール (high density lipoprotein-cholesterol:hdl-c) 血症はそれぞれ動脈硬化促進因子である. 高 TG 血症ではレムナントやsmall dense LDL(low

More information

ヒト血漿中オキシステロールの高感度分析法

ヒト血漿中オキシステロールの高感度分析法 High sensitive determination of oxysterols in human plasma using gas chromatography-mass spectrometry (GC-MS) Saori Nakagawa and Susumu Yamato Oxysterols, cholesterol oxidation products, have been important

More information

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.

More information

untitled

untitled ORYZA POLYAMINE ORYZA POLYAMINE -P -PC -LC 1. Ver.1.0 MM ver. 1.0MM 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504

More information

STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U

STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical University, Kashihara (Director: Prof. H. Nakano) This

More information

15K00827 研究成果報告書

15K00827 研究成果報告書 (TG) TG sterol regulatory element- binding protein (SREBP)-1c (Diabetes 53:560-569, 2004) SREBP-1c (1) SREBP-1c SREBP-1c liver X receptor (LXR)LXR O-Glc NAc (O-linked -N-acetyl glucosamine) (J Biol Chem

More information

Noninvasive estimation of pulmonary capillary wedge pressure and cardiac output by the analysis of pulmonary venous flow velocity patterns in patients

Noninvasive estimation of pulmonary capillary wedge pressure and cardiac output by the analysis of pulmonary venous flow velocity patterns in patients Noninvasive estimation of pulmonary capillary wedge pressure and cardiac output by the analysis of pulmonary venous flow velocity patterns in patients with acute congestive heart failure Jung-Myung Lee,

More information

76 LOrthopédie 1a 1b ,530 3, , , / Ⅱ

76 LOrthopédie 1a 1b ,530 3, , , / Ⅱ 9275 842016 2016 1 25 4546 Ⅰ 1874 7 188720 190134 192312 193712 194924 142 1920 6 1880 5 6 1954 Orthopedic surgery 1741Nicolas Andry LOrthopédie Andrystraightfree from deformity orthoschild paidion Orthopédie

More information

1) Michaelis L. Biochem Z., 59, 78, 1914. 2) Ferris H. C. Dent. Cosmos Phila., 63, 10, 93, 1921. 3) Bloomfield A. L. Bull Johns Hopk. Hosp. Bait., 31, 118, 1920. 4) Starr H. C. J. Biol. Chem. Bait., 54,

More information

HILIC UPLC/MS UPLC LC/ MS LC/MS HPLC 2-4 HPLC 4,5 HILIC / HILIC 80 ACQUITY UPLC Xevo QTof MS ACQUITY BEH HILIC HILIC TOF ESI 1.7 µm BEH HILIC UPLC HIL

HILIC UPLC/MS UPLC LC/ MS LC/MS HPLC 2-4 HPLC 4,5 HILIC / HILIC 80 ACQUITY UPLC Xevo QTof MS ACQUITY BEH HILIC HILIC TOF ESI 1.7 µm BEH HILIC UPLC HIL HILIC UPLC/MS UPLC LC/ MS LC/MS HPLC 2-4 HPLC 4,5 HILIC / HILIC 80 ACQUITY UPLC Xevo QTof MS ACQUITY BEH HILIC HILIC TOF ESI 1.7 µm BEH HILIC UPLC HILIC UPLC HPLC 1 100 µl 900 µl 15 900 µl 500 µl 470 µl

More information

好酸球性副鼻腔炎:診断ガイドライン(JESREC Study)

好酸球性副鼻腔炎:診断ガイドライン(JESREC Study) 118 728 2015 : : JESREC Study Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis Study : JESREC Study CT NSAIDs CT : JESREC Study JESREC Study 118 729 ph CTMRI Caldwell Luc

More information

2001 2003 2005 2006 2007 2008

2001 2003 2005 2006 2007 2008 2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65

More information

Ⅱ 方法と対象 1. 所得段階別保険料に関する情報の収集 ~3 1, 分析手法

Ⅱ 方法と対象 1. 所得段階別保険料に関する情報の収集 ~3 1, 分析手法 67 論文 要旨 : 1507 キーワード : Ⅰ 緒言 65 2014 89 5 2 3 5 6 2 5 6 3 4 3 4 2006 2015 9 9 68 2018. 3 2015 Ⅱ 方法と対象 1. 所得段階別保険料に関する情報の収集 6 2015 7 2016 2 ~3 1,507 2. 分析手法 69 3 3 3 A B C 3 A 4 1 1 2 2 2014 2014 2014 5

More information

越智59.qxd

越智59.qxd Social Skills Training; SST SST Social Skills, SST, ;, SST, SST SST, ;, ; DeRosier & Marcus,, ;, a b SST Ladd & Mize, ; Hansen, Nagle, & Meyer,,, A BC SST SST SST SST SST SST, SST Goldstein & McGinnis,

More information

CHEMOTHERAPY AUG. 1982 VOL. 30 NO. 8 CHEMOTHERAPY Fig.1 Relation between various-closis of cefazolin and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection

More information

PhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3

PhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3 1 9 2017-05-06 Marie Spano, MS, RD 185 AND CSSD 2 9 2017-05-06 PhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3 3 136 EPA D 46 B12 B12 B12 2010 98

More information

23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213

More information

多目的な障害予防のための「ニコニコ体操」

多目的な障害予防のための「ニコニコ体操」 "Enjoyable Exercises" as multipurpose prevention exercise Koji Yamashita1) Department of Physical Therapy, Faculty of Health Sciences, Aomori University of Health and Welfare 13)Marras WS, Ferguson

More information

1)Malmivaara A, Hakkinen U, et al: The treatment of acute low back pain - bed rest, exercise, or ordinary activity? N Engl J Med 1995;332:251-5 2)Latash ML: Spectral analysis of the electromyogram (EMG)

More information

遺伝子ネットワーク解析

遺伝子ネットワーク解析 1.3 atsushi_doi@cell-innovator.com 6-10-1 I 2 http://www.cell-innovator.com 1 2 23andMe, GeneQuest, MYCODE DNA RNA DNA RNA DNA A, T, G, C RNA or = BioCyc (EcoCyc) KEGG Reactome WikiPathways TRANSPATH

More information

23 3 11 21 24 28 4 31,371 20,822 34,511 21,720 12,278 9,574 7,502 137,778 1 69 83.49% 70 15.55% 0.96 3.61% 40 1.19% 1055 29.65% 28 10 1 2 230,250 43,150 656 138,000 137,832 137,820 121,000 30,000 246,800

More information

The positive correlation between bad breath and subgigival microflora OTakafumi Department of Periodontics, Tokyo Dental College MORIYAMA, Masatake TS

The positive correlation between bad breath and subgigival microflora OTakafumi Department of Periodontics, Tokyo Dental College MORIYAMA, Masatake TS A study of ultrasonic scaling with regard to the changes of bacterial phase in the periodontal pocket Department of Periodontology, *Preventive Dentistry, **Bacteriology, Osaka Dental University Masatoshi

More information

1) Steinbrocker, O.: The shoulder-hand syndrome in reflex dystrophy of the upper ex- tremity, Ann. Intern. Med., 29: 22, 1948. 5) Greenfield, A. D. M., Whitney, R. J. and Mowbray, J. F.: Methods for the

More information

本文/研究フロンティア_伊藤先生

本文/研究フロンティア_伊藤先生 Women s Health Initiative WHI hormone replacement therapy, HRT coronary heart disease, CHD HRT HRT conjugated equine estrogen, CEE medroxyprogesterone acetate, WHI WHI Fournier P DG WHI CHD E-selectin

More information

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ 29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27

More information

JC47602’ÓFC

JC47602’ÓFC J Cardiol 2006 Jun; 476: 307 312 1 Regression of a Large Lipid-Rich Pool in the Coronary Artery During Treatment With Statin Detected by Intravascular Ultrasound: A Case Report 1 2 3 Hiroaki Tatsuya Yukio

More information

_02.indd

_02.indd 30, 11-16, 2010 Z Z score Computed tomography ROC analysis 3 CT 1,2 CT 1/3 3 5 CT CT 6 7,8 MCA ASPECTS Alberta Stroke Programme Early CT Score 4 10 CT ASPECTS 50% 9 Z 10 CT Z CT 10 Z Z Z receiver operating

More information

「長寿のためのコレステロール ガイドライン2010 年版」に対する声明

「長寿のためのコレステロール ガイドライン2010 年版」に対する声明 長寿のためのコレステロールガイドライン 2010 年版 に対する声明 平成 22 年 9 月 1 日に 脂質栄養学会 コレステロールガイドライン策定委員会 という組織から 標記 ガイドライン 1) が発表された この内容をめぐる一部のメディアの報道により 一般の方々のみならず 患者やその家族の方々の間にも コレステロールに関する認識に 混乱を招いている 日本動脈硬化学会は 動脈硬化性疾患予防ガイドライン

More information

JC38603

JC38603 J Cardiol 2001 Dec; 386: 337 342 : 3 Coronary Artery Dissection Following Angioplasty Evaluated by Fractional Flow Reserve: Report of Three Cases Kazutaka AMAYA, MD Kenji TAKAZAWA, MD, FJCC Nobuhiro TANAKA,

More information

1911~20 1921~30 1931~40 area M area A area I *p

More information

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版 ...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html

More information

顔面神経麻痺を来したMPO―ANCA 陽性の中耳炎2症例

顔面神経麻痺を来したMPO―ANCA 陽性の中耳炎2症例 11367 : MPOANCA MPO ANCA MPOANCA 134EU MPO ANCA 67EU MPOANCA ANCA : MPOANCAANCA antineutrophil cytoplasmic antibody ; ANCA Davies IgG ANCA PR3proteinase3ANCA MPOmyeloperoxidaseANCA Wegener PR3ANCA MPO

More information

v

v v CONTENTS 1 2 7 2 14 COLUMN 15 RAGEAGEs 21 COLUMN 22 26 COLUMN NADPH 28 32 COLUMN GLP1 36 39 COLUMN AGEs 44 46 54 COLUMN GWAS 55 59 3 66 COLUMN 69 COLUMN 1 2 71 vi 4 78 84 89 COLUMN GFR decliner 92 94

More information

untitled

untitled 1) American College of Surgeons:Advanced Trauma Life Support Course Manual. American College of Surgeons 1997;103-112 24 2) American Society of Anesthesiologists Task Force:Practice guideline for blood

More information

14UNAIDS HIV 39% i 9 ii9iii UNAIDS x.9x.9x1= ?? UNAIDS % 77%8% 44.7x.77x.8x1=

14UNAIDS HIV 39% i 9 ii9iii UNAIDS x.9x.9x1= ?? UNAIDS % 77%8% 44.7x.77x.8x1= DeCEMBER, 17 No.34 HIV 169-73 1-1-1-13TEL 3-5937-4413:3 19:3 FAX 3-5937-443E-mail info@janpplus.jp http://janpplus.jp/!9-9-9!... 1-3 POSITIVE HIV/AIDS UNAIDS!... 4-5 JaNP+HIV Cafe Bar an opportunity...

More information

Microsoft Word - 【最終】05.PRECISE-IVUSプレスリリース原稿案

Microsoft Word - 【最終】05.PRECISE-IVUSプレスリリース原稿案 国立大学法人熊本大学 報道機関各位 平成 27 年 7 月 28 日 熊本大学 二つの薬の併用で冠動脈プラークを劇的に退縮 - 心筋梗塞発症予防に向けた新たな治療法 - 熊本大学大学院生命科学研究部循環器内科学 ( 小川久雄教授 ) の辻田賢一講師らは 標準的な脂質低下治療薬 スタチン と併用してコレステロール吸収阻害薬 エゼチミブ 投与することで 標準的な治療に比べて強力な脂質低下効果と冠動脈プラーク退縮

More information

untitled

untitled Tl Thallium CAS 7440-28-0 CH 3 COOTl Thallium Acetate CAS 563-68-8 Tl 2 CO 3 Thallium Carbonate CAS 6533-73-9 Tl 2 SO 4 Thallium Sulfate CAS 7446-18-6 TlNO 3 Thallium Nitrate CAS 10102-45-1 TlClO 3 Thallium

More information

WHO Library Cataloguing in Publication Data 2003, Wilkinson,Richard Marmot,Michael Social determinants of health SDH The social gradient Stress Early life Social exclusion Work Unemployment Social support

More information